9-97313272-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_020893.6(CCDC180):āc.386A>Gā(p.Gln129Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,612,104 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_020893.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC180 | NM_020893.6 | c.386A>G | p.Gln129Arg | missense_variant | 5/37 | ENST00000529487.3 | NP_065944.3 | |
SUGT1P4-STRA6LP-CCDC180 | NR_036528.1 | n.1941A>G | non_coding_transcript_exon_variant | 19/51 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC180 | ENST00000529487.3 | c.386A>G | p.Gln129Arg | missense_variant | 5/37 | 1 | NM_020893.6 | ENSP00000434727 | P1 | |
CCDC180 | ENST00000494917.6 | n.589A>G | non_coding_transcript_exon_variant | 6/20 | 1 | |||||
CCDC180 | ENST00000460482.6 | n.729A>G | non_coding_transcript_exon_variant | 6/21 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000638 AC: 97AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000736 AC: 185AN: 251434Hom.: 0 AF XY: 0.000780 AC XY: 106AN XY: 135894
GnomAD4 exome AF: 0.00113 AC: 1649AN: 1460012Hom.: 1 Cov.: 30 AF XY: 0.00110 AC XY: 801AN XY: 726250
GnomAD4 genome AF: 0.000638 AC: 97AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.000659 AC XY: 49AN XY: 74302
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at